PNC FINANCIAL SERVICES GROUP, INC. - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,720
-18.3%
5440.0%0.00%
Q2 2023$2,106
+18.4%
544
-15.3%
0.00%
Q1 2023$1,778
+53.8%
6420.0%0.00%
Q4 2022$1,156
-42.2%
642
-7.9%
0.00%
Q3 2022$2,0000.0%697
+8.6%
0.00%
Q2 2022$2,000
-87.5%
642
-78.6%
0.00%
Q4 2021$16,0003,0000.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
AH Equity Partners Bio II, L.L.C. 16,298,006$70,733,00040.75%
Madrona Venture Group, LLC 6,020,770$26,130,0007.74%
AH Equity Partners LSV II, L.L.C. 1,355,911$5,885,0004.24%
Ally Bridge Group (NY) LLC 1,080,566$4,690,0003.48%
ArchPoint Investors 1,449,551$6,291,0002.17%
Tikvah Management LLC 1,488,895$6,462,0002.07%
Bain Capital Life Sciences Investors, LLC 2,000,000$8,680,0000.84%
Perceptive Advisors 9,111,151$39,542,0000.79%
SPHERA FUNDS MANAGEMENT LTD. 840,000$3,646,0000.52%
Decheng Capital Management III (Cayman), LLC 300,000$1,302,0000.40%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders